▲ Peaking
Business
🔮 fades
With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access
Merck is finalizing voluntary licensing agreements and expanded access programs for its monthly experimental HIV prevention pill ahead of potential approval.